Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.884
-0.002 (-0.26%)
Nov 5, 2024, 11:17 AM EST - Market open
Gossamer Bio Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Gossamer Bio stock have an average target of 9.20, with a low estimate of 4.00 and a high estimate of 15. The average target predicts an increase of 940.72% from the current stock price of 0.88.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 17, 2024.
Analyst Ratings
The average analyst rating for Gossamer Bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,031.22% | Sep 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,031.22% | Aug 30, 2024 |
| Wedbush | Wedbush | Buy Reiterates $4 | Buy | Reiterates | $4 | +352.49% | Aug 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $9 | Buy | Initiates | $9 | +918.10% | Jun 25, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +804.98% | Jun 17, 2024 |
Financial Forecast
Revenue This Year
118.47M
Revenue Next Year
16.51M
from 118.47M
Decreased by -86.06%
EPS This Year
-0.27
from -1.18
EPS Next Year
-0.72
from -0.27
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 179.8M | 43.7M | 126.4M | ||
| Avg | 118.5M | 16.5M | 47.2M | ||
| Low | 93.9M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | -63.1% | 665.6% | ||
| Avg | - | -86.1% | 185.7% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.07 | -0.54 | 0.25 | ||
| Avg | -0.27 | -0.72 | -0.40 | ||
| Low | -0.42 | -1.07 | -0.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.